Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
55,813,953
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1,621,133
-
Shares change
-
+1,621,133
-
Total reported value, excl. options
-
$2,443,403
-
Value change
-
+$2,443,403
-
Number of buys
-
15
-
Price
-
$1.48
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) as of Q3 2025
As of 30 Sep 2025 Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,621,133 shares of stock of the company.
Largest 10 holders included BML Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, Koa Wealth Management, LLC, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MONOGRAPH WEALTH ADVISORS, LLC, HRT FINANCIAL LP, and CITIGROUP INC.
This table shows 15 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.